(Q36813439)

16 August 2017

1 reference

title

Late relapse of testis cancer (English)

1 reference

16 August 2017

Yaron Ehrlich

1

1 reference

16 August 2017

Jack Baniel

series ordinal

2

1 reference

16 August 2017

publication date

1 May 2007

1 reference

Urologic Clinics of North America

16 August 2017

published in

1 reference

16 August 2017

volume

34

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

253-8; abstract x-xi

1 reference

Testicular germ-cell cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late relapse of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late relapse of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late relapse of germ cell tumors after cisplatin-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Surveillance in stage I testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Update on late relapse of germ cell tumor: a clinical and molecular analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

The pathology of late recurrence of testicular germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Secondary surgery in germ cell tumors--when and how extensively should it be performed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Clinical study of six cases showing late relapse of germ cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.02.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2007.02.012

1 reference

16 August 2017

1 reference